Financials

  • Market Capitalization 425.29 M
  • Employee 73
  • Founded 2005
  • CEO Jason Okazaki
  • Website www.assemblybio.com
  • Headquarter Delaware, United States
  • FIGI BBG000R62Q06
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-61.84
Rapporto prezzo/fatturato
5.27

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3027
EVMN
Evommune, Inc. Common Stock
12.00 USD-0.91%-8.33%-42.25%-30.72%432.22 M USD
3032
STRO
Sutro Biopharma, Inc. - Common Stock
26.03 USD-6.50%-18.38%-13.23%+49.68%431.33 M USD
3050
PBYI
Puma Biotechnology Inc - Common Stock
8.28 USD+2.48%+4.81%+12.20%+133.24%421.45 M USD
3052
CCCC
C4 Therapeutics, Inc. - Common Stock
3.81 USD-2.81%-10.77%-0.52%+78.04%421.26 M USD

Notizie